83 related articles for article (PubMed ID: 15748444)
1. [Effect of tetrandrine combined with Droloxifen on the expression of bcr/abl of K562 at both mRNA and protein levels].
Chen BA; Qian XJ; Cheng J; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):95-9. PubMed ID: 15748444
[TBL] [Abstract][Full Text] [Related]
2. [Effect of tetrandrine in combination with droloxifen on the expression of NF-kappaB protein in K562 and K562/A02 cell lines].
Su AL; Chen BA; Huang CY; Gao F; Cheng J; Xu WL; Shen HL; Sun XC; Cheng HY; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Chen NN; Zhao HH
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):321-4. PubMed ID: 18844070
[TBL] [Abstract][Full Text] [Related]
3. [Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo].
Wu D; Lin MF; Zhao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):373-8. PubMed ID: 15972123
[TBL] [Abstract][Full Text] [Related]
4. [Using protein chips to study mechanism underlying reversion of drug resistance in leukemia cells in tetrandrine alone or in combination with droloxifene].
Chen BA; Du J; Zhang CX; Cheng J; Gao F; Lu ZH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):999-1003. PubMed ID: 16403267
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.
Wu LX; Xu JH; Huang XW; Zhang KZ; Wen CX; Chen YZ
Acta Pharmacol Sin; 2006 Jun; 27(6):694-9. PubMed ID: 16723087
[TBL] [Abstract][Full Text] [Related]
6. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
Dilloo D; Hanenberg H; Lion T; Burdach S
Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
[TBL] [Abstract][Full Text] [Related]
7. [Detection of bcr-abl fusion gene mRNA level in K562/A02 cell line by real-time quantitative RT-PCR].
Chen BA; Zhou GN; Cheng J; Qiao C; Wu YJ; Li JY; Ding JH; Gao C; Zhao G; Wang J; Bao W; Song HH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):40-3. PubMed ID: 21362218
[TBL] [Abstract][Full Text] [Related]
8. [Gene of DNA-dependent protein kinase catalylic subunit in chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):248-52. PubMed ID: 17493325
[TBL] [Abstract][Full Text] [Related]
9. [Study on mismatch repair genes of chronic myeloid leukemia].
Luo J; Peng ZG; Chen Y; Lai YR; Lu YY; Song SJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):103-6. PubMed ID: 16732964
[TBL] [Abstract][Full Text] [Related]
10. [Synergism of As2S2 and STI 571 in inducing apoptosis of K562 cells].
Li JE; Sun GL; Wu YL; Wu WL
Zhonghua Xue Ye Xue Za Zhi; 2003 Nov; 24(11):580-3. PubMed ID: 14720443
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression.
Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155
[TBL] [Abstract][Full Text] [Related]
12. Apoptotic effect of As2S2 on K562 cells and its mechanism.
Li JE; Wu WL; Wang ZY; Sun GL
Acta Pharmacol Sin; 2002 Nov; 23(11):991-6. PubMed ID: 12421474
[TBL] [Abstract][Full Text] [Related]
13. Curcumin synergistically augments bcr/abl phosphorothioate antisense oligonucleotides to inhibit growth of chronic myelogenous leukemia cells.
Zhang KZ; Xu JH; Huang XW; Wu LX; Su Y; Chen YZ
Acta Pharmacol Sin; 2007 Jan; 28(1):105-10. PubMed ID: 17184589
[TBL] [Abstract][Full Text] [Related]
14. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of lithium chloride-induced proliferation inhibition and apoptosis of K562 leukemic cells].
Tang HR; He Q; Wang FC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):979-82. PubMed ID: 16403263
[TBL] [Abstract][Full Text] [Related]
16. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
17. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
18. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].
Wu Y; Chen Y; Hu J
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].
Shi DX; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284
[TBL] [Abstract][Full Text] [Related]
20. [Using real-time polymerase chain reaction to quantitate bcr-abl mRNA].
Liu JX; Liu JL; Wang GJ
Ai Zheng; 2006 Nov; 25(11):1447-9. PubMed ID: 17094919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]